PHILIP%SHAHEEN%
61#Valleyview#Drive,#Sydney,#NS,#B1R2L5#|#(902)539>1470#|#philipshaheen@hotmail.com#
!"#$%&'()*
Dalhousie#University,#Halifax,#NS#
+,-./012*13*4-5/6-/*7.,28,-9*:;;<*
#
Dalhousie#University,#Halifax,#NS#
+,-./012*13*4-5/6-/*$./85=>29*?%@A,6-/@*B,C12D* EFFG*
#
%""'&'()%H*!"#$%&'()*
Dalhousie#University,#Halifax,#NS#
7.,28,-101I9*13*$./81>./2,J9*K2,@L,>/*$1L2=/#M,6L,29*:;E:*N*%J250*:;E:#
*
7O%PB%$Q*!R7!P'!)$!*
Dalhousie#University#%LIL=>*:;ES*N*J2/=/6>#
%@CL6->*7213/==12#(College#of#Pharmacy)#
Revised#case>based#learning,#therapeutics#lecturing#and#testing#for##
Pathocytologic+Disorders#fourth#year#student#course.#
#
Cape#Breton#Regional#Hospital/Cape#Breton#Cancer#Centre#M,6L,29*:;EE*N*J2/=/6>#
(6-101I9*7.,28,-5=>* *
Improved#cancer#treatment#preparation#through#implementation#of#lean#processes.##
Units#include#ambulatory#and#inpatient#adult#oncology,#pediatrics#and#rural#sites.##
Updated#formulary#listings#and#improved#adherence.##Pharmacy#representation#for#
oncologic#studies.#
Cape#Breton#Regional#Hospital#B,9*:;E;*N*J2/=/6>#
7.,28,-5=>* *
Verification#of#inpatient#medication#orders.##Involvement#in#parenteral#nutrition#policy#
review#group.#
Sobeys#Pharmacy/Lawtons#Drugs# # ML6/*:;;<*N*B,9*:;E;#
7.,28,-5=>T*B,6,I/2*
Provision#of#pharmaceutical#care#and#technical#prescription#checking.##Oversight#of#
staff#scheduling,#third#party#billing#and#inventory#management.#
#
%""'&'()%H*()$(H(KQ*7O%PB%$Q*!R7!P'!)$!*
)/U*$,6-/2*"2LI*VL6@*H5,5=16*?$,J/*+2/>16*$,6-/2*$/6>2/D*M,6L,29*:;E<*N*J2/=/6>*
Education#on#new#drug#approvals#and#improved#billing#processes#of#New#Cancer#Drug#
Fund#(Dept.#of#Health)#submissions.##
$.,52N*$./81>./2,J9*W12X56I*K21LJ*?$,J/*+2/>16*$,6-/2*$/6>2/D*(->1Y/2*:;E<*Z*B,9*:;ES*
Coordination#and#oversight#of#Medical#Day#Unit#establishment.##Upgrade#and#expansion#
planning#of#Chemotherapy#Treatment#Room#and#Chemotherapy#Pharmacy#Satellite.#
*
721C/->*H/,@*$,J/*+2/>16*$,6-/2*$/6>2/*$./81>./2,J9*4,>/005>/*721C/->*4/J>/8Y/2*:;EEN*%LI*:;E:*
PHILIP%SHAHEEN%PAGE%2%
Researched#and#established#current#chemotherapy#preparation#satellite,#Furthered#lean#
processes#and#developed#technician#chemotherapy#checking#training#and#certification#
program.#
#
7#+H'$%&'()4*%)"*7P!4!)&%&'()4*
+“In+Its+Proper+Place:+Establishing+a+Medical+Day+Unit”#
Poster#acceptance#at#the#Fall#Cancer#Care#Nova#Scotia#Provincial#Cancer#Network#Meeting##########:;E[*
+
“Pharmacy+toolkits+for+oral+systemic+therapy+agents:+Just@in@time+information+for+the+practicing+pharmacist”+
(Co@author)+Journal+of+Oncology+Pharmacy+Practice+Volume+20+#3+June+2014+
Selected#for#platform#presentation#at#the#International#Society#of#Oncology#Pharmacy#
Practitioners#Symposium#(Montreal)#:;E[#
“Bringing+the+Team+Together:+Establishment+of+a+Chemotherapy+Pharmacy+Satellite”+
Poster#acceptance#the#Annual#Meeting#of#Pharmacy#Association#of#Nova#Scotia#(Halifax),#
and#the#National#Oncology#Pharmacy#Symposium#(Vancouver)#:;E<*
#
H%)K#%K!4*
[English#–#native#language]#
#
B!B+!P4O'74*
7.,28,-9*%==1-5,>516*13*)1A,*4-1>5,*?7%)4)#[member]#ML6/*:;;<*N*J2/=/6>#
# #
$,6,@5,6*%==1-5,>516*13*7.,28,-9*56*(6-101I9*?$%7.(D#M,6L,29*:;E:*N*J2/=/6>#
Communications#Committee#(member)#
CAPhO#2020#Professional#Strategic#Planning#Task#Force#(member)#
#
$,6-/2*$,2/*)1A,*4-1>5,*?$$)4D*M,6L,29*:;EE*N*J2/=/6>*
Provincial#Systemic#Therapy#Committee#(member)#
Provincial#Oral#Chemotherapy#Working#Group#(member)#
Provincial#Oncology#Therapy#Subcommittee#(District#representative)#
#
)1A,*4-1>5,*O/,0>.*%L>.125>9*!,=>/26*\16/]$,J/*+2/>16*$,6-/2*$/6>2/*M,6L,29*:;EE*N*J2/=/6>*
Eastern#Zone#Quality#Cancer#Committee#(Pharmacy#representative)#
Cape#Breton#Cancer#Centre#Revitalizing#and#Restructuring#Project#Committee#(member)#4/J>/8Y/2*:;E<*N*J2/=/6>#
Cape#Breton#Cancer#Centre#Medical#Day#Unit/Chemotherapy#Treatment#Working#Group#(chair)#
Cape#Breton#Cancer#Centre#Leadership#Committee#(member)#V/Y2L,29*:;ES*Z*J2/=/6>*
*
#
#
%W%P"4]P!$(K)'&'()4*
Dr.#J#McKnight#–#M#Fleming#Hospital#Pharmacy#Award#(Dalhousie#University)#:;;<#
Natural#Medicines#Comprehensive#Database#Recognition#Award#(Dalhousie#University)#:;;<*
Cancer#Care#Nova#Scotia#Excellence#in#Patient#Care#Award#(Nominee)#:;E[*
Cancer#Care#Nova#Scotia#Leadership#Excellence#Award#(Recipient)*:;ES*
* *
*
#
1 / 2 100%
La catégorie de ce document est-elle correcte?
Merci pour votre participation!

Faire une suggestion

Avez-vous trouvé des erreurs dans linterface ou les textes ? Ou savez-vous comment améliorer linterface utilisateur de StudyLib ? Nhésitez pas à envoyer vos suggestions. Cest très important pour nous !